Priam De Villalonga
Priam De Villalonga received his M.S. degree in pharmacy from the University of Barcelona, Spain, in 1996. He did his Ph.D. degree in Neus Agell’s lab at the School of Medicine in the University of Barcelona, Spain, working on Ras regulation by Calmodulin (CaM) and its role in cell-cycle progresión. After his Ph.D. degree (UB, 2001, awarded the extraordinary prize in the School of Medicine), he joined Anne J. Ridley’s lab at the Ludwig Institute for Cancer Research (UCL) in London, where he was awarded an EMBO postdoctoral fellowship. His postdoctoral work there was focused on the role of a novel member of the Rho GTPase family, RhoE/Rnd3, on the regulation of cell cycle progression and oncogenic transformation. In 2005, he joined the University of the Balearic Islands, where he was awarded a Ramón y Cajal fellowship. In 2007, together with Dr. Silvia Fernández de Mattos, he established the Cancer Cell Biology Laboratory. He is presently continuing his work on RhoE’s role in cell proliferation and transformation, and in collaboration with clinical fellows, he has started new projects to explore novel therapeutic strategies in Gliomas, a type of brain tumor constituting one of the worst human cancers according to its clinical aggressiveness and dismal prognosis.
Biography Updated on 8 February 2012